Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.325
Bid: 1.30
Ask: 1.35
Change: 0.00 (0.00%)
Spread: 0.05 (3.846%)
Open: 1.325
High: 1.325
Low: 1.325
Prev. Close: 1.325
XSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants, Issue of Equity and TVR

2 Feb 2024 07:00

RNS Number : 7789B
Xeros Technology Group plc
02 February 2024
 

Xeros Technology Group plc

('Xeros", the "Company" or the "Group")

 

 

Exercise of Warrants, Issue of Equity

 

and

 

Total Voting Rights

 

Successful warrant process raises c.£1.68 million additional cash for the Company

 

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, announces that further to the amendments to the terms of the warrants to subscribe for ordinary share of 0.1 pence each (respectively "Warrants" and "Ordinary Shares") as approved by warrant holders on 21 December 2023, the Company has issued 44,961,489 new Ordinary Shares following receipt of valid notices of exercise at the amended Warrant exercise price of 2.85 pence per Ordinary Shares. 16,065,575 of these new Ordinary Shares will be admitted to trading on AIM by way of the Company's existing block admission arrangements, and separate application for the remaining 28,895,914 Ordinary Shares has been made by the Company, with admission to trading on AIM expected to occur on 7 February 2024 ("Admission").

 

Warrants Now Expired

 

The final exercise date for the Warrants was 31 January 2024 at 5.00 pm. In aggregate, the Company received valid exercise notices in respect of 58,916,729 Warrants in total, raising c.£1.68 million during the exercise period. The remaining 68,078,911* Warrants have now expired.

 

Total Voting Rights

 

Following Admission, the Company's issued share capital will consist of 209,896,852 Ordinary Shares with voting rights, with no shares held in treasury. This figure may therefore be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital pursuant to (i) the Company's Articles, (ii) the Financial Conduct Authority's Disclosure Guidance and Transparency Rules and/or (iii) the AIM Rules for Companies issued by the London Stock Exchange plc as amended from time to time.

 

 

 

Enquiries

 

Xeros Technology Group plc

Neil Austin, Chief Executive Officer

Alex Tristram, Director of Finance

 

Tel: 0114 269 9656

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

 

Tel: 020 7220 0570

Belvedere PR

Cat Valentine

Keeley Clarke

xeros@belvederepr.com

Mob: 07715 769 078

Mob: 07967 816 525

 

*200,000 Warrants were unable to be issued following the Fundraise in September 2022 due to the necessary registration details not being provided to the Company.

 

About Xeros

 

Xeros Technology plc has developed patented and proven, industry-leading technologies which reduce the environmental impact of how industries make and care for clothes.

 

The traditional wet processing methods used in industrial and domestic laundry and garment manufacturing consume billions of litres of fresh water and large amounts of energy and chemicals, as well as damaging and weakening clothing fibres and creating rising levels of environmental pollution. It is estimated that washing machines contribute 35% of the 171 trillion microplastic particles in the ocean.

 

A range of actors, including consumers, the media NGOs and regulators are exerting pressure on these industries, with legislative action beginning to be taken.

 

Xeros' three main technologies, Filtration, Finish, and Care, facilitate garment manufacturers, industrial laundries, domestic washing machine manufacturers and consumers, to reduce their environmental impact, whilst also significantly improving efficiency in the process.

 

Xeros' model is to generate revenue from licensing its technologies, generating royalties and the sale of consumables. Currently there are 8 agreements in place. The addressable markets in Filtration, Finish and Care are estimated to be valued at £350m p.a., £132m p.a. and £3bn p.a. respectively.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESSSFAFELSEFE
Date   Source Headline
7th Jan 202112:15 pmRNSHolding(s) in Company
24th Dec 202012:41 pmRNSSecond Price Monitoring Extn
24th Dec 202012:36 pmRNSPrice Monitoring Extension
1st Dec 20203:46 pmRNSDirector/PDMR Shareholding and Issue of Options
27th Nov 20204:37 pmRNSPrice Monitoring Extension
25th Nov 202010:30 amRNSResult of General Meeting
25th Nov 20207:00 amRNSFirst XDrum sales in Denim Finishing market
9th Nov 20207:00 amRNSProposed Share Capital Reorganisation
6th Nov 20209:15 amRNSHolding(s) in Company
29th Sep 20204:17 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
16th Sep 20209:30 amRNSHolding(s) in Company
8th Sep 202011:10 amRNSNotice of Results
3rd Aug 20209:30 amRNSApplication for Block Listing
22nd Jul 20209:15 amRNSBlock Listing Six Monthly Return
16th Jul 20204:21 pmRNSHolding(s) in Company
16th Jul 20207:00 amRNSXFiltra rated best laundry microparticle filter
14th Jul 20204:41 pmRNSSecond Price Monitoring Extn
14th Jul 20204:36 pmRNSPrice Monitoring Extension
11th Jun 202010:00 amRNSResult of AGM
3rd Jun 20202:45 pmRNSHolding(s) in Company
1st Jun 202012:30 pmRNSHolding(s) in Company
1st Jun 20207:00 amRNSCompletion of Sale of Marken Business
27th May 20207:00 amRNSXeros technology cleaning French key worker PPE
26th May 20204:00 pmRNSHolding(s) in Company
20th May 20204:15 pmRNSHolding(s) in Company
19th May 20204:45 pmRNSPublication of Annual Report & Notice of AGM
15th May 20203:15 pmRNSHolding(s) in Company
14th May 20205:45 pmRNSHolding(s) in Company
14th May 20208:01 amRNSDirector/PDMR Shareholding, Issue of Options & TVR
13th May 202011:00 amRNSResult of General Meeting
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20203:30 pmRNSResult of Fundraising
24th Apr 202011:00 amRNSProposed Placing, PrimaryBid Offer & Notice of GM
24th Apr 202011:00 amRNSPrimaryBid.com Offer
24th Apr 202011:00 amRNSUnaudited Preliminary Results
14th Apr 20204:40 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSFormer C&A Innovation Head Advises Xeros
19th Mar 20207:00 amRNSLicensing Agreement With Leading Asian OEM
17th Mar 20207:00 amRNSDevelopment Agreement for Microplastic Filtration
16th Mar 20204:42 pmRNSSecond Price Monitoring Extn
16th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 202012:08 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 202012:07 pmRNSSecond Price Monitoring Extn
12th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSSale of Marken Business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.